The University of Toledo in Ohio has launched a cancer research institute to support interdisciplinary collaboration among more than 60 clinicians and researchers at the university. The Northwest Ohio Cancer Research Institute will also partner with Toledo-based ProMedica and the…
The Latest
Mark Cuban Cost Plus Drug Co. has added Vegzelma, a biosimilar indicated for six cancer types, to its marketplace for hospitals and other healthcare providers. The company plans to expand its biosimilar offerings amid growing demand for biologics among health…
Overall cancer mortality is 2 to 2.6 times higher among individuals with a high school degree or lower, according to the American Cancer Society’s “Report on the Status of Cancer Disparities in the United States, 2025” published Dec. 16 in…
Uninsured children and adolescents with cancer have a higher risk of dying within five years compared to their peers with private insurance, according to a Dec. 15 Scientific American report. Here are four notes from the report: Read the full…
Some U.S. hospitals and health systems are marking up generic cancer drugs by more than five times their commercial rates, Bloomberg reported Dec. 17. Bloomberg analyzed data from the price transparency platform Turquoise Health. Of the more than 1,700 hospitals…
Los Angeles-based Cedars-Sinai has received a $30 million gift from the Cayton Goldrich Family Foundation to establish the Cedars-Sinai Cayton BRCA Center. The new center will focus on research, diagnosis and treatment of cancers linked to mutations in the BRCA1…
New Hyde Park, N.Y.-based Northwell Health and San Antonio-based START Center for Cancer Research opened a $5.7 million early-phase clinical trial facility Dec. 16 at Northwell’s R.J. Zuckerberg Cancer Center in Lake Success, N.Y. The Northwell-START New York-Long Island center includes 14…
Smilow Cancer Hospital at Greenwich in Connecticut will receive a $25 million grant recommended by an anonymous donor in support of expanded cancer services. The gift will support the hospital’s building fund and is being made in honor of Dickerman…
Boston-based Dana-Farber Cancer Institute will pay $15 million to settle a lawsuit with the U.S. Department of Justice related to allegations of fraud that occurred between 2014 and 2024 in connection with National Institutes of Health research grants. As part…
Conshohocken, Pa.-based pharmaceutical company Cencora plans to acquire the majority of the outstanding equity interests it does not currently own in OneOncology from TPG for approximately $3.6 billion, according to a Dec. 15 press release. OneOncology is a physician-led platform that supports…